指南与共识儿科与产科急症重症综合管理与镇静镇痛

肾功能不全危重患儿的药物处方:临床实践与临床决策支持推荐意见的比较

Drug prescribing in critically ill children with kidney impairment: Comparing clinical practice with clinical decision support recommendations.
指南 / 共识 · Int J Med Inform · 2026-04-08
一句话结论在20例肾功能不全的PICU患儿中,11次需要调整剂量的处方有8次(73%)与PEDeDose临床决策支持系统的推荐一致。

该回顾性观察性可行性研究分析了2023年巴塞尔大学儿童医院PICU中肾功能不全患儿的电子健康记录,评估PEDeDose临床决策支持系统调整药物剂量推荐与临床实践的一致性。436例患者中纳入20例(5%),其中7例(33%)被处方了因肾功能不全需要调整剂量的药物,这些患者中共有11次处方需要调整剂量,其中8次(73%)的调整与CDSS推荐一致。作者认为临床实践与CDSS推荐一致性良好,PEDeDose可能有助于肾功能不全儿童的剂量调整和处方质量维持。

要点

  • 436例PICU患者中仅20例(5%)肾功能不全患儿被纳入分析,其中7例(33%)被处方了需要调整剂量的药物。
  • 这些患儿中共11次处方需要调整剂量,8次(73%)的剂量调整与PEDeDose CDSS推荐一致。
  • 作者认为临床实践与CDSS推荐在儿科剂量调整方面一致性良好。
  • 作者认为PEDeDose可能有助于肾功能不全儿童的剂量调整和处方质量维持,其获益可能不限于专科大学医院环境。

适用人群与场景

  • 2023年巴塞尔大学儿童医院PICU的肾功能不全患儿,取自电子健康记录。

研究设计与关键结果

  • 研究类型为回顾性观察性可行性研究,分析了2023年巴塞尔大学儿童医院PICU肾功能不全患儿的药物处方,提取年龄、体重、身高、PICU住院时长、给药记录、血清肌酐和胱抑素C值及诊断。
  • 436例患者中纳入20例(5%),其中7例(33%)被处方了因肾功能不全需要调整剂量的药物。
  • 这些患者中共11次处方需要调整剂量,其中8次(73%)的剂量调整与PEDeDose CDSS推荐一致。

证据类型、等级与局限

  • 证据类型:回顾性观察性可行性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床实践与PEDeDose CDSS推荐在儿科剂量调整方面一致性良好,支持PEDeDose辅助肾功能不全儿童剂量调整和维持处方质量的潜力。
  • 作者认为,考虑到该患者群体处方复杂性,PEDeDose提供的支持可能使儿科患者及其照护者获益,且不限于专科大学医院环境。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The kidneys play a crucial role in eliminating drugs, and their functional impairment can lead to drug accumulation and adverse effects. To prevent this, drug dosages (doses or administration intervals) are adjusted based on kidney function using the Glomerular Filtration Rate (GFR). Calculating dosages is an error prone task, particularly in paediatric patients where individual dosing strategies can be complex.

AIM: This study assessed the potential application of a novel feature of the paediatric clinical decision support system (CDSS) PEDeDose that calculates adjusted drug dosages for children with impaired kidney function. Renal dosing practices in a paediatric intensive care patients with impaired kidney function were compared to recommendations provided by PEDeDose.

METHODS: This retrospective observational feasibility study analysed drug prescriptions in patients with impaired kidney function from electronic health records of the paediatric intensive care unit (PICU) of the University Children's Hospital Basel in 2023. Extracted data included patients' age, weight, height, and length of PICU stay, drug administration records, serum creatinine and cystatin C values, and diagnoses. The primary outcome was the frequency of dosage adjustments adherent to CDSS' recommendations.

RESULTS: Out of 436 patients, 20 (5%) patients were included. In this study of 20 patients, 7 (33%) were prescribed drugs that required dosage adjustments due to their impaired kidney function. Across these patients, dosage adjustment was indicated in 11 prescriptions, and 8 (73%) of these dosages were adjusted as recommended by the CDSS.

CONCLUSION: The study observed good concordance between clinical practice and the CDSS' recommendations on dosage adjustment in paediatrics. This supports the potential of PEDeDose to facilitate dosing and maintain quality of drug prescribing in children with kidney impairment. Considering the complexity of drug prescribing in this patient population, the support provided by PEDeDose may benefit paediatric patients and their caregivers beyond a specialised university hospital setting.

来源:Int J Med Inform,查看原文。版权归原作者所有。

参考来源

  1. Higi L, Wälti M, Gotta V, et al. Drug prescribing in critically ill children with kidney impairment: Comparing clinical practice with clinical decision support recommendations. Int J Med Inform. 2026. PMID: 41955912. doi:10.1016/j.ijmedinf.2026.106414

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。